Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.5.0.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:        
Net earnings (loss) $ 169 $ 41 $ 738 $ 159
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]        
Depreciation and amortization 92 96 272 272
Stock-based compensation 41 56 109 147
Share of (earnings) loss of affiliates, net (37) (29) (43) 8
Realized and unrealized (gains) losses on financial instruments, net (7) 200 33 188
Deferred income tax expense (benefit)     407 98
Other, net     35 20
Changes in operating assets and liabilities        
Current and other assets     (29) (141)
Payables and other current liabilities     129 142
Net cash provided (used) by operating activities     1,651 893
Cash flows from investing activities:        
Investments in and loans to cost and equity investees     (762)  
Proceeds from Sale of Available-for-sale Securities     61 175
Proceeds (payments) from settlement of financial instruments, net     (1) (88)
Capital expended for property and equipment     (318) (176)
Purchases of short term investments and other marketable securities     (258) (51)
Sales of short term investments and other marketable securities     273 231
Other investing activities, net     (5) (40)
Net cash provided (used) by investing activities     (1,010) 51
Cash flows from financing activities:        
Borrowings of debt     2,019 1,779
Repayments of debt     (876) (818)
Repurchases of Liberty common stock       (303)
Shares repurchased by subsidiary     (1,225) (1,648)
Proceeds from Liberty Braves common stock rights offering     203  
Taxes paid in lieu of shares issued for stock-based compensation     (43) (51)
Other financing activities, net     20 4
Net cash provided (used) by financing activities     98 (1,037)
Net increase (decrease) in cash and cash equivalents     739 (93)
Cash and cash equivalents at beginning of period     201 681
Cash and cash equivalents at end of period $ 940 $ 588 $ 940 $ 588